Semaglutide dosing and titration: the full schedule, and what each dose step costs
0.25 mg to 2.4 mg: the label titration schedule, how long it takes, and the chart that shows why flat-rate pricing matters more with every dose escalation.
The Wegovy dose ladder
The label is specific for weight management: start 0.25 mg once weekly for 4 weeks, then 0.5 mg, then 1.0 mg, then 1.7 mg, each held about 4 weeks, reaching the 2.4 mg maintenance dose at week 17. The escalation exists to reduce gastrointestinal side effects; if a dose isn't tolerated, prescribers may hold or slow the increase. If a dose is missed by more than 5 days, guidance is to skip it and resume the schedule.
| Dose step | Duration | Earliest week | Note |
|---|---|---|---|
| 0.25 mg (start) | 4 weeks | Week 1 | Initiation; not maintenance |
| 0.5 mg | 4 weeks | Week 5 | Escalation |
| 1.0 mg | 4 weeks | Week 9 | Escalation |
| 1.7 mg | 4 weeks | Week 13 | Escalation |
| 2.4 mg (maintenance) | ongoing | Week 17 | Target maintenance dose |
How long titration realistically takes
The standard schedule reaches 2.4 mg at about 16 weeks, but many prescribers go slower for patients with side effects, and some patients maintain at a lower dose (e.g., 1.0 or 1.7 mg) if that's where they tolerate and respond well. The goal is the maximum tolerated effective dose, not necessarily the label maximum.
What each dose step costs — where pricing model matters
On a flat-rate plan the dose ladder is clinically driven; on dose-tiered plans, every rung costs money. At typical dose-tiered prices, reaching and maintaining 2.4 mg adds over $140/month versus the starting dose — and you spend most of your treatment life at maintenance.
What to ask before you enroll
Three questions that change the financial picture: (1) "What will I pay per month at 2.4 mg?" — not at the starting dose. (2) "Is there an extra charge to pause or slow titration?" (3) "Does a dose-change consultation cost extra?" On a bundled flat-rate plan like NexLife's, the answers are usually favorable; on minimal or membership plans, they vary. Ask before enrolling — the sticker price won't show it. See our price-trends page for the full math.
Ozempic vs Wegovy dosing — and why it confuses pricing
Semaglutide's dosing story is genuinely confusing because the same molecule is sold under two brands with two different dose ceilings, and compounded programs borrow from both. Ozempic, approved for type 2 diabetes, titrates to a maximum of 2.0 mg weekly. Wegovy, approved for weight management, goes higher, to the 2.4 mg maintenance dose that the STEP trials used. Compounded programs may target either endpoint depending on the clinical rationale, which means "semaglutide" on two different programs' price sheets can refer to meaningfully different maintenance doses — and therefore different value.
This is why comparing monthly prices without pinning down the dose is a trap. A program advertising a low price at a diabetes-style dose isn't directly comparable to one pricing a weight-management dose, even though both say "semaglutide." When you request quotes, specify the maintenance dose you and your prescriber are targeting and ask for the price at that dose, not the starter price. On a flat-rate plan this distinction collapses — you pay the same regardless — which is part of flat-rate's underrated appeal: it removes an entire axis of comparison complexity.
There's also a clinical safety layer to the compounded dosing question. Because compounded products often come as multi-dose vials with syringes rather than pre-measured pens, the patient does more of the measuring, and the FDA has specifically warned about dosing errors with compounded GLP-1s. A program that provides clear instructions, appropriate supplies, and responsive support when you're unsure how to draw a dose is mitigating a real risk — another instance where the service wrapped around the molecule, not just the molecule's price, determines what you're actually getting. Dosing itself is always a decision for your prescriber.
Frequently asked questions
What is the semaglutide dosing schedule?
For weight management (Wegovy), start at 0.25 mg once weekly for 4 weeks, then escalate every 4 weeks — 0.5, 1.0, 1.7 mg — to the 2.4 mg maintenance dose at about week 17. The escalation reduces gastrointestinal side effects.
How long does it take to reach the full semaglutide dose?
The standard schedule reaches 2.4 mg at about 16 weeks. Many prescribers titrate more slowly based on tolerability, and some patients maintain at a lower dose if that's where they tolerate and respond best.
Does semaglutide dose affect monthly cost?
On flat-rate pricing: no — you pay the same at 0.25 mg and 2.4 mg. On dose-tiered pricing: yes — each escalation can add cost, so reaching 2.4 mg (where most patients maintain) can cost over $140/month more than the advertised starter price.
What is the maintenance dose of semaglutide?
For weight management, the target maintenance dose is 2.4 mg once weekly. Some patients maintain effectively at 1.0 or 1.7 mg if higher doses aren't tolerated. The right dose is a clinical decision made with a prescriber.
References
- Novo Nordisk. Wegovy (semaglutide) Prescribing Information — dosing and administration.
- Wilding JPH, et al. STEP 1 dose-escalation protocol. N Engl J Med. 2021.
- Semaglutide Price Guide July 2026 price report and trends page.
- Semaglutide Price Guide price-by-dose reference.
Clinical figures from published trials and FDA labeling; pricing from provider-advertised rates checked July 2026 and subject to change. Educational, not medical or financial advice.